DaVita HealthCare Partners Aktie 1139087 / US23918K1088
149.84
USD
-4.47
USD
-2.90%
30.12.2024
BTT
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Watchlist | |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
Kurse + Charts + Realtime
News + Analysen
Fundamental
zugeh. Wertpapiere
DaVita HealthCare Partners Dividenden Kalender
| Datum | Name | Rendite * | Dividende | Währung |
|---|---|---|---|---|
| 2023 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2022 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2021 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2020 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2019 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2018 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2017 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2016 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2015 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
| 2014 | DaVita HealthCare Partners Inc | 0.00 | 0.00 | USD |
Gewinn je Aktie- DaVita HealthCare Partners
| 7.4 23 | 5.8 22 | 8.9 21 | 6.3 20 | 5.3 19 | 0.9 18 | 3.5 17 |
Umsatz je Aktie- DaVita HealthCare Partners
| 130 23 | 121 22 | 106 21 | 94.2 20 | 74.0 19 | 66.2 18 | 56.8 17 |
KGV- DaVita HealthCare Partners
| 14.1 23 | 13.1 22 | 12.8 21 | 18.4 20 | 14.2 19 | 55.9 18 | 20.8 17 |
DaVita HealthCare Partners Inc: Die Aktie (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie berichtet | 7.42 | 5.85 | 8.90 | 6.31 | 5.27 | 0.92 | 3.47 |
| Gewinn je Aktie unverwässert | 7.62 | 5.88 | 9.30 | 6.54 | 5.29 | 0.93 | 3.52 |
| Gewinn je Aktie verwässert | 7.42 | 5.71 | 8.90 | 6.39 | 5.27 | 0.92 | 3.47 |
| Dividende pro Aktie | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gesamtdividendenausschüttung in Mio. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
DaVita HealthCare Partners Inc: Unternehmenskennzahlen (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatz je Aktie | 130.28 | 121.15 | 105.68 | 94.20 | 74.04 | 66.17 | 56.84 |
| KGV (Jahresendkurs, EPS unverwässert) | 14.12 | 13.08 | 12.78 | 18.38 | 14.23 | 55.93 | 20.82 |
| KGV (Jahresendkurs, EPS verwässert) | 14.12 | 13.08 | 12.78 | 18.38 | 14.23 | 55.93 | 20.82 |
| KGV (Jahresendkurs) | 14.12 | 13.08 | 12.78 | 18.38 | 14.23 | 55.93 | 20.82 |
| Dividendenrendite Jahresende in % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Eigenkapitalquote in % | 15.57 | 12.58 | 13.27 | 16.31 | 19.36 | 26.05 | 30.80 |
| Fremdkapitalquote in % | 84.43 | 87.42 | 86.73 | 83.69 | 80.64 | 73.95 | 69.20 |
DaVita HealthCare Partners Inc: GuV (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Umsatzerlöse | 12’140.15 | 11’609.89 | 11’618.80 | 11’550.60 | 11’388.48 | 11’404.85 | 10’876.63 |
| Umsatzveränderung in % | 4.57 | -0.08 | 0.59 | 1.42 | -0.14 | 4.86 | -26.24 |
| Bruttoergebnis vom Umsatz | 3’074.99 | 2’667.74 | 2’965.77 | 2’931.56 | 2’858.84 | 2’629.30 | 2’679.72 |
| Bruttoergebnisveränderung in % | 15.27 | -10.05 | 1.17 | 2.54 | 8.73 | -1.88 | -20.67 |
| Operatives Ergebnis | 1’601.00 | 1’312.54 | 1’770.43 | 1’683.97 | 1’755.53 | 1’501.15 | 1’622.73 |
| Veränderung Operatives Ergebnis in % | 21.98 | -25.86 | 5.13 | -4.08 | 16.95 | -7.49 | -8.51 |
| Ergebnis vor Steuern | 1’177.09 | 966.28 | 1’518.49 | 1’318.26 | 1’195.44 | 1’048.48 | 1’399.79 |
| Veränderung Ergebnis vor Steuern in % | 21.82 | -36.37 | 15.19 | 10.27 | 14.02 | -25.10 | -5.98 |
| Ergebnis nach Steuer | 691.54 | 546.95 | 978.45 | 783.30 | 706.83 | 624.32 | 901.28 |
| Veränderung Ergebnis nach Steuer in % | 26.44 | -44.10 | 24.91 | 10.82 | 13.22 | -30.73 | 2.43 |
DaVita HealthCare Partners Inc: Bilanz (in Mio. USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gesamtverbindlichkeiten | 14’876 | 15’455 | 15’500 | 14’865 | 14’578 | 14’287 | 13’252 |
| Langzeit Gesamtverbindlichk. pro Aktie | 137.73 | 141.97 | 134.67 | 112.70 | 97.00 | 56.47 | 55.96 |
| Eigenkapital | 2’743 | 2’225 | 2’371 | 2’897 | 3’500 | 5’033 | 5’897 |
| Veränderung Eigenkapital in % | 48.26 | -5.72 | -45.39 | -35.15 | -42.39 | -21.04 | 0.90 |
| Bilanzsumme | 17’619 | 17’680 | 17’871 | 17’762 | 18’078 | 19’320 | 19’149 |
| Veränderung Bilanzsumme in % | -0.34 | -1.07 | 0.61 | -1.75 | -6.43 | 0.89 | -0.79 |
DaVita HealthCare Partners Inc: Sonstige Angaben (in USD)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Gewinn je Aktie (unverwässert) | 7.62 | 5.88 | 9.30 | 6.54 | 5.29 | 0.93 | 3.52 |
| Veränderung Gewinn je Aktie (unverwässert) in % | 29.50 | -36.74 | 42.21 | 23.50 | 469.28 | -73.58 | -19.27 |
| Gewinn je Aktie (verwässert) | 7.42 | 5.71 | 8.90 | 6.39 | 5.27 | 0.92 | 3.47 |
| Veränderung Gewinn je Aktie (verwässert) in % | 30.03 | -35.87 | 39.32 | 21.15 | 473.10 | -73.49 | -19.11 |
| Anzahl Mitarbeiter | 70’000 | 70’000 | 69’000 | 67’000 | 65’000 | 77’700 | 74’500 |
| Veränderung Anzahl Mitarbeiter in % | 0.00 | 1.45 | 2.99 | 3.08 | -16.34 | 4.30 | 5.97 |
DaVita HealthCare Partners Inc Termine
| Unternehmen | Event | Datum |
|---|---|---|
| DaVita HealthCare Partners Inc | Quartalszahlen | 18.02.2025 |
| DaVita HealthCare Partners Inc | Quartalszahlen | 13.05.2025 |
| DaVita HealthCare Partners Inc | Quartalszahlen | 31.07.2025 |
| DaVita HealthCare Partners Inc | Quartalszahlen | 11.11.2025 |
DaVita HealthCare Partners Inc vergangene Termine
| Terminart | Info | Datum |
|---|---|---|
| Quartalszahlen | Q3 2024 Earnings Release | 29.10.2024 |
| Quartalszahlen | Q2 2024 Earnings Release | 06.08.2024 |
| Hauptversammlung | Annual General Meeting | 06.06.2024 |
| Quartalszahlen | Q1 2024 Earnings Release | 02.05.2024 |
| Quartalszahlen | Q4 2023 Earnings Release | 13.02.2024 |
| Quartalszahlen | Q3 2023 Earnings Release | 07.11.2023 |
| Quartalszahlen | Q2 2023 Earnings Release | 03.08.2023 |
| Hauptversammlung | Annual General Meeting | 06.06.2023 |
| Quartalszahlen | Q1 2023 Earnings Release | 08.05.2023 |
| Quartalszahlen | Q4 2022 Earnings Release | 22.02.2023 |
| Quartalszahlen | Q3 2022 Earnings Release | 28.10.2022 |
| Quartalszahlen | Q2 2022 Earnings Release | 01.08.2022 |
| Hauptversammlung | Annual General Meeting | 09.06.2022 |
| Quartalszahlen | Q1 2022 Earnings Release | 05.05.2022 |
| Quartalszahlen | Q4 2021 Earnings Release | 10.02.2022 |
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 95.51 |
| Berkshire Hathaway, Inc. | 44.02 |
| Berkshire Hathaway, Inc. (Investment Management) | 44.02 |
| The Vanguard Group, Inc. | 7.71 |
| Vanguard Group, Inc. (Subfiler) | 6.30 |
| State Street Corp. | 2.94 |
| Ted R Weschler | 2.66 |
| BlackRock Fund Advisors | 2.32 |
| Vanguard Total Stock Market ETF | 1.62 |
| Vanguard 500 Index Fund | 1.49 |
| BlackRock Institutional Trust Co. NA | 1.49 |
| Geode Capital Management LLC | 1.42 |
| LSV Asset Management | 1.29 |
| Vanguard Small Cap Index Fund | 1.28 |
| Invesco Capital Management LLC | 1.21 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 74’500 | 77’700 | 65’000 | 67’000 | 69’000 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0.15 | 0.15 | 0.18 | 0.17 | 0.17 |
Bilanz (in Mio. USD) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8’744 | 8’424 | 3’690 | 3’149 | 3’168 |
| Summe Anlagevermögen | 10’405 | 10’896 | 14’388 | 14’613 | 14’703 |
| Summe Aktiva | 19’149 | 19’320 | 18’078 | 17’762 | 17’871 |
Bilanz (in Mio. USD) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 13’252 | 14’287 | 14’578 | 14’865 | 15’500 |
| Summe Eigenkapital | 5’897 | 5’033 | 3’500 | 2’897 | 2’371 |
| Summe Passiva | 19’149 | 19’320 | 18’078 | 17’762 | 17’871 |
Adresse
| 2000 16th Street, 80202-7198 Denver | |
| Telefon | +1 (720) 631-2100 |
| URL | http://www.davita.com |
Management
|
Adam H. Schechter
Independent Director |
|
Alan Cullop
Chief Information Officer |
|
Andrew Mohraz
Associate General Counsel & Head-Investigations |
|
Barbara Jean Desoer
Independent Non-Executive Director |
|
Bruce E. Ware
Vice President |
|
Charles G. Berg
Independent Director |
|
Christopher M. Berry
Chief Accounting Officer |
|
David P. Maughan
Chief Operating Officer |
|
Dennis W. Pullin
Independent Director |
|
Gregory J. Moore
Independent Director |
|
James O. Hearty
Chief Compliance Officer |
|
Jason M. Hollar
Independent Director |
|
Javier J. Rodriguez
Chief Executive Officer & Director |
|
Jeffrey A. Giullian
Chief Medical Officer-Kidney Care |
|
Jeffrey Wagner
Senior Vice President |
|
Jessica Hergenreter
Chief People Officer |
|
Joel Ackerman
Chief Financial Officer & Treasurer |
|
Kathleen Alyce Waters
Chief Legal & Public Affairs Officer |
|
Madhu Narasimhan
Chief Information Officer |
|
Mahesh Krishnan
Group Vice President-Growth |
|
Michael D. Staffieri
Chief Operating Officer-Emeritus |
|
Nic Eliason
Investor Relations Contact |
|
Pamela M. Arway
Independent Chairman |
|
Phyllis R. Yale
Independent Non-Executive Director |
|
Samantha A. Caldwell
Secretary |
|
Wendy Lee Schoppert
Independent Director |